Risk Factors Associated with Statin-Associated Muscle Symptoms in Patients Attending a Specialized Regional Lipid Clinic
Table 2
Lists of concomitant medications of SAMS vs. non-SAMS patients.
No SAMS ()
SAMS ()
Number of medications
4.0
4.4
0.448
On antihypertensive medications
Yes (%)
41.2
57.6
0.016
On antidiabetic medications
Yes (%)
19.5
16.9
0.634
On pain killers
Yes (%)
13.9
13.6
0.949
On aspirin/clopidogrel
Yes (%)
21.6
25.4
0.508
On thyroid medications
Yes (%)
11.8
10.2
0.718
On asthma medications
Yes (%)
7.6
6.8
0.829
On antidepressant medication
Yes (%)
22.1
15.3
0.229
On proton pump inhibitors
Yes (%)
18.9
22.0
0.566
On other lipid-lowering agents
Yes (%)
52.5
49.2
0.625
values represent the level of significance of the difference between patients who have developed SAMS and non-SAMS patients, calculated using the chi-square test. For the numerical, an independent samples -test was used to test association.
